Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. STXS
STXS logo

STXS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

STXS News

Stereotaxis Reports 36% Revenue Growth in Q4

19h agoYahoo Finance

Stereotaxis Q4 2025 Earnings Call Insights

21h agoseekingalpha

Stereotaxis Q4 Earnings Report Analysis

1d agoseekingalpha

Stereotaxis to Announce Q4 Earnings on March 9th

3d agoseekingalpha

Stereotaxis Receives FDA Approval for MAGiC Magnetic Ablation Catheter

Jan 06 2026NASDAQ.COM

Stereotaxis Receives FDA Approval for MAGiC Catheter, Advancing Cardiac Treatment Technology

Jan 06 2026Globenewswire

Key Analyst Recommendations for Tuesday: Nvidia, Tesla, Roku, Estee Lauder, Southwest, Gap, MetLife, and Others

Dec 16 2025CNBC

Will Refurbished Xi Systems Expand ISRG's Presence from Hospitals to ASCs?

Nov 26 2025NASDAQ.COM

STXS Obtains FDA Approval for GenesisX to Expand Surgical Robotics

Nov 13 2025NASDAQ.COM

Roth Capital Affirms Buy Rating for Stereotaxis, Keeps $4 Price Target Intact

Nov 12 2025Benzinga

Major Stock Movers on Wednesday: AMD, ALC, and Others

Nov 12 2025SeekingAlpha

Stereotaxis Stock Declines as Q3 Loss Increases, GenesisX Limited Launch in Progress

Nov 12 2025SeekingAlpha

Stereotaxis Inc. (STXS) Announces Q3 Loss and Falls Short of Revenue Projections

Nov 11 2025NASDAQ.COM

Earnings Report for November 11, 2025: ALC, OKLO, DOX, CAE, ORLA, SMWB, HYLN, LPTH, STXS, PAL, EPM, QUIK Released After Market Hours

Nov 11 2025NASDAQ.COM

Stereotaxis and CardioFocus Partner to Enhance Robotic Pulsed Field Ablation for Heart Rhythm Disorders

Oct 13 2025Newsfilter

STXS Shares Rise Following Erasmus Medical's Adoption of Genesis Robotic System

Sep 23 2025NASDAQ.COM